🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This mechanistic study will evaluate the effect of vildagliptin on glucose-...
Status
Completed
Location
Diabetes Zentrum Bad Lauterberg
Start Date
2006-10
Trial ID
NCT00396071
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of vildagli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01497522
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of vildaglip...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01582230
Treatments Being Tested
Animal models have demonstrated that incretins have a glucose-independent e...
Status
Completed
Location
Diabetes and Vascular Research Department
Start Date
2010-05
Trial ID
NCT01122641
Treatments Being Tested
The purpose of the study is to assess if the addition of vildagliptin as ad...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-05
Trial ID
NCT01862263
Treatments Being Tested
To evaluate vildagliptin as compared to gliclazide, given in combination wi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-01
Trial ID
NCT01758380
Treatments Being Tested
This is a multicenter, randomized, double-blind, parallel, Vildagliptin and...
Status
Unknown
Location
The Second People's Hospital of Hefei
Start Date
2021-09-30
Trial ID
NCT05102149
Treatments Being Tested
Many people with type 2 diabetes cannot maintain target blood glucose level...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-03
Trial ID
NCT00106340
Treatments Being Tested
The purpose of the study was to evaluate the efficacy and safety of LMF237 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-05
Trial ID
NCT01811485
Treatments Being Tested
The purpose of this study was to assess the efficacy and safety of vildagli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-12
Trial ID
NCT02002221
Treatments Being Tested